Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00141180
Status:
COMPLETED
Last Update Posted:
2006-07-25
First Post:
2005-08-30
Brief Title:
CP-481715 Nickel Allergy Study
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Placebo-Controlled Randomized Parallel Group Multiple-Dose Study to Evaluate the Effects of CP-481715 on Clinical Response and Cellular Infiltration Following Contact Allergen Challenge to the Skin of Nickel Allergic Subjects
Status:
COMPLETED
Status Verified Date:
2005-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None